Evidence map›Paper›PMID 35046756›Full record

ArticleContrast media & molecular imaging2021

GlyCEST: Magnetic Resonance Imaging of Glycine-Distribution in the Normal Murine Brain and Alterations in 5xFAD Mice.

Ken Ohno, Masaki Ohkubo, Bingwen Zheng, Masaki Watanabe, Tsuyoshi Matsuda, Ingrid L Kwee, Hironaka Igarashi

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contrast media & molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Ken OhnoCenter for Integrated Human Brain Science, Brain Research Institute, University of Niigata, Niigata 951-8585, Japan.ORCID 0000-0003-3876-3719
Masaki OhkuboDepartment of Radiological Technology, School of Health Sciences, Faculty of Medicine, University of Niigata, Niigata 951-8518, Japan.
Bingwen ZhengTime Medical Ltd., Hong Kong Science & Technology Park, Hong Kong, China.
Masaki WatanabeCenter for Integrated Human Brain Science, Brain Research Institute, University of Niigata, Niigata 951-8585, Japan.
Tsuyoshi MatsudaDivision of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, Iwate 028-3694, Japan.
Ingrid L KweeDepartment of Neurology, University of California Davis, CA 94553, USA.
Hironaka IgarashiCenter for Integrated Human Brain Science, Brain Research Institute, University of Niigata, Niigata 951-8585, Japan.ORCID 0000-0003-1663-5564
Niigata University · JPHong Kong Science and Technology Parks Corporation · HKIwate Medical University · JPNiigata University of Health and Welfare · JPUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glycine level in the brain is known to be altered in neuropsychiatric disorders, such as schizophrenia and Alzheimer's disease (AD). Several studies have reported the

Indexed as

Alzheimer DiseaseGlycineAnimalsBrainMagnetic Resonance ImagingMiceMice, Inbred C57BLGlycine

Identifiers

PMID35046756
PMCPMC8739925
OpenAlexW4200047757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.